| Salmon Pharma GmbH - Medikinet MR 30 mg, Kapseln | | 56847 | | 03 | | Medikinet MR 30 mg | | Kapseln | | N06BA04 | | Methylphenidat | | 13.02.2009 | | |
| | Composition | | methylphenidati hydrochloridum 30 mg, sacchari sphaerae corresp. saccharum 69.6-79.61 mg et maydis amylum, poly(alcohol vinylicus), talcum, macrogolum 3350, polysorbatum 80, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas, natrii hydroxidum, triethylis citras, simeticonum, methylcellulosum, silica colloidalis anhydrica, E 132, aluminii oxidum hydricum, E 200, Kapselhülle: gelatina, natrii laurilsulfas, aqua purificata, E 127, E 132, E 171, E 172 (nigrum) pro capsula corresp. natrium 0.07 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Principe actif | Concentr. |
|---|
| Methylphenidate Hydrochloride | 30 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Methylphenidate Hydrochloride | 30 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | Acidi Methacrylici | | | | Aluminii Oxidum Hydricum | | | | Aqua Purificata | | | | E 127 | | color. | | E 132 | | color. | | E 171 | | color. | | E 172 | | color. | | E 200 | | conserv. | | Ethylis Acrylatis Polymerisatum | | | | Gelatina | | Kapselhülle | | Macrogol | 3350 | | | Maydis Amylum | | | | Methylcellulosum | | | | Sodium Hydroxide | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | | | Polysorbatum 80 | | | | Sacchari Sphaerae | | | | Silica Colloidalis Anhydrica | | | | Simeticone | | | | Talcum | | | | Triethylis Citras | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 30 Gélule(s) | | | A+ | | Oui | | 041 | 20 Gélule(s) | | | A+ | | Oui | | 042 | 50 Gélule(s) | 65.18 | 87.30 | A+ | LS | Non | | 043 | 100 Gélule(s) | 108.85 | 134.80 | A+ | LS | Non |
|
|
